Skip to content
value.today

CirrusMD Inc.

🇺🇸 Denver, Colorado, USATechnologyFounded 2012
Total raised
$45 M
5 rounds on record
Latest round
$20 M
Mar 2021
First round on record
Dec 2014
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CirrusMD Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2021$20 MNo. 5$10 to $50 million

CirrusMD Inc.: Raise no. 5, Mar 2021

Investors in this round

13 investors had bought by the notice of Jun 22, 2021: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Altorfer · Executive Officer, Director, Promoter
  • Gabe Varela · Executive Officer
  • James C.T. Linfield · Executive Officer
  • John Jepsen · Executive Officer, Promoter
  • Wallace Blake Mckinney · Executive Officer
  • Jeff Cook · Director
  • Kelsey C.T. Maguire · Director
  • Molly Bonakdarpour · Director
  • Ryan Kirkpatrick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andrew Altorfer, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 22, 2021. Read the notice at the SEC.

equitySEC
Feb 2019$15 MNo. 4$10 to $50 million

CirrusMD Inc.: Raise no. 4, Feb 2019

Investors in this round

37 investors had bought by the notice of May 2, 2019: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Christian Altorfer · Executive Officer, Director
  • Gabe Blake Varela · Executive Officer
  • M. Christian Saxman · Executive Officer
  • Wallace Blake Mckinney · Executive Officer, Director
  • Jeff Blake Cook · Director
  • Ken Blake Hanover · Director
  • Kyle Blake Williams · Director
  • Molly Blake Mccartin · Director
  • Ryan Blake Kirkpatrick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christian Saxman, Chief Financial Officer. Source: SEC Form D, newest notice filed May 2, 2019. Read the notice at the SEC.

equitySEC
Jun 2017$7 MNo. 3$2 to $10 million

CirrusMD Inc.: Raise no. 3, Jun 2017

Investors in this round

39 investors had bought by the notice of Jun 20, 2017: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$10,440
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Altorfer · Executive Officer, Director · Co-Founder and Chief Executive Officer
  • Christian Saxman · Executive Officer · Chief Financial Officer
  • Wallace McKinney · Executive Officer, Director · Co-Founder and Chief Medical Officer
  • Elliot Sands · Director
  • Ken Hanover · Director
  • Kyle Williams · Director
  • Ryan Kirkpatrick · Director
  • Sean Kearney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A and A-1 Preferred Stock”

Signed by Chris Saxman, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 20, 2017. Read the notice at the SEC.

equitySEC
Mar 2016$1 MNo. 2Under $2 million

CirrusMD Inc.: Raise no. 2, Mar 2016

Investors in this round

20 investors had bought by the notice of Mar 15, 2016: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
$5,555
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Altorfer · Executive Officer, Director · Chief Executive Officer
  • Chris Saxman · Executive Officer · Chief Operating Officer
  • Elliot Sands · Director
  • Jim Kasic · Director
  • Ryan Kennedy · Director
  • Wallace Mckinney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christian Saxman, Chief Operating Officer. Source: SEC Form D, newest notice filed Mar 15, 2016. Read the notice at the SEC.

equitySEC
Dec 2014$2 MNo. 1Under $2 million

CirrusMD Inc.: Raise no. 1, Dec 2014

Investors in this round

37 investors had bought by the notice of Jan 14, 2015: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them, other: The offering consists of Series Seed Preferred Stock with previously issued convertible promissory notes converting into Series Seed Preferred Stock and Common Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Altorfer · Executive Officer, Director · Chief Executive Officer
  • Chris Blake Saxman · Executive Officer · Chief Operating Officer
  • Elliot Blake Sands · Director
  • Wallace Blake McKinney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount includes the combined aggregate amounts of each of the Series Seed Preferred Stock and Common Stock.”

Signed by M. Christian Saxman, Chief Operating Officer. Source: SEC Form D, newest notice filed Jan 14, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CirrusMD Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2021).

    SEC Form D · Jun 2021

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jun 2021

That is all the official record says: CirrusMD Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CirrusMD Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 39 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CirrusMD Inc.
NameRoleNamed in
Andrew AltorferExecutive officerJun 2021
Gabe VarelaExecutive officerJun 2021
James C.T. LinfieldExecutive officerJun 2021
John JepsenExecutive officerJun 2021
Wallace Blake MckinneyExecutive officerJun 2021
Andrew Christian AltorferExecutive officerMay 2019
Gabe Blake VarelaExecutive officerMay 2019
M. Christian SaxmanExecutive officerMay 2019
Christian SaxmanChief Financial OfficerJun 2017
Wallace McKinneyCo-Founder and Chief Medical OfficerJun 2017
Chris SaxmanChief Operating OfficerMar 2016
Chris Blake SaxmanChief Operating OfficerJan 2015
Andrew AltorferDirectorJun 2021
Jeff CookDirectorJun 2021
Kelsey C.T. MaguireDirectorJun 2021
Molly BonakdarpourDirectorJun 2021
Ryan KirkpatrickDirectorJun 2021
Andrew Christian AltorferDirectorMay 2019
Jeff Blake CookDirectorMay 2019
Ken Blake HanoverDirectorMay 2019
Kyle Blake WilliamsDirectorMay 2019
Molly Blake MccartinDirectorMay 2019
Ryan Blake KirkpatrickDirectorMay 2019
Wallace Blake MckinneyDirectorMay 2019
Elliot SandsDirectorJun 2017
Ken HanoverDirectorJun 2017
Kyle WilliamsDirectorJun 2017
Sean KearneyDirectorJun 2017
Wallace McKinneyCo-Founder and Chief Medical OfficerJun 2017
Jim KasicDirectorMar 2016
Ryan KennedyDirectorMar 2016
Wallace MckinneyDirectorMar 2016
Elliot Blake SandsDirectorJan 2015
Wallace Blake McKinneyDirectorJan 2015
Andrew AltorferPromoterJun 2021
John JepsenPromoterJun 2021